Zercepac will be available for HER2-positive breast and gastric cancers
Updated Date: Thu, 17 Sep 2020 00:00:00 EDT
Updated Date: Thu, 17 Sep 2020 00:00:00 EDT
Updated Date: Thu, 17 Sep 2020 00:00:00 EDT
Updated Date: Thu, 17 Sep 2020 00:00:00 EDT
Updated Date: Thu, 17 Sep 2020 00:00:00 EDT
A High Court judge has suggested that the General Medical Council should rethink the way it formulates charges […]
The US Centers for Disease Control and Prevention provoked controversy when it changed information about airborne transmission of […]
The US Food and Drug Administration (FDA) “will not delay, but will not cut corners” in approving a […]
UK-headquartered company will characterise autoantibody profiles of clinical trial patients